Cancer FrontiersCancer is more than 100 diseases, and whether one can be cured depends on its type, its stage and the treatments that can reach it. Here is what doctors mean by cure, remission and “no evidence of disease.”
Cancer FrontiersTargeted drugs, checkpoint inhibitors, CAR-T cells and biomarker testing have joined surgery, radiation and chemotherapy. Each works differently, helps some patients dramatically and others not at all.
AI + MedicineIn breast screening, AI support has been tested in a randomized trial of more than 100,000 women and a real-world study of 460,000. The results are promising, but false alarms, overdiagnosis and deskilling still matter.
BreakthroughsKilling diseased cells in a dish is the easy part of drug development. This guide explains the evidence ladder, why most candidates fail, and seven questions to ask before believing a breakthrough headline.
Genome + CellsFrom the $3 billion Human Genome Project to routine sequencing, reading DNA has become easy. Here is what a genome can reveal today, and where uncertain variants, risk scores and missing context set hard limits.
Genome + CellsIn December 2023 the FDA approved Casgevy, the first CRISPR-based therapy, for sickle cell disease. Here is how gene editing, gene therapy and RNA medicines differ, and what that approval does and doesn't prove.
LongevityLongevity claims are everywhere, but human evidence is thin. This field guide sorts the most popular anti-ageing ideas by what has been shown in animals, what has been tested in people, and what nobody knows yet.
BreakthroughsA positive Phase 1 result and a positive Phase 3 result sound similar but mean very different things. Here is what each stage of a clinical trial is designed to show, and what it cannot.
LongevitySome longevity metrics, like blood pressure, are backed by decades of evidence and clear actions. Others, like consumer biological-age tests, are promising research tools whose meaning for individuals is not yet settled.
BreakthroughsHealth headlines often overstate early findings, sometimes before a journalist ever sees them. These seven questions help anyone judge a medical claim in about two minutes before sharing it.